This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Vice President Global Marketing
Chris brings to BrainsWay more than 15 years of medical device commercial and business development experience in both privately-held and multi-billion dollar medical device companies. He is responsible for increasing BrainsWay’s adoption in the market and overseeing the continued development of the BrainsWay brand.
Chris previously was with Drake Partners LLC, a start-up private equity and management consulting firm, where he served as Managing Director and led commercial activities for many of its portfolio companies. Before joining Drake Partners, he was Vice President of Sales and Marketing at St. Jude Medical (now part of Abbott), where Chris managed the commercial integration of NeuroTherm, Inc. into the St. Jude’s Chronic Pain Therapies division. Prior to St. Jude, he was the Vice President of America Sales and Global Marketing for NeuroTherm, an international pain management company, where Chris played a key role in transforming the sales and marketing organizations to accelerate the company’s revenue growth and its overall enterprise value. Earlier in his career, he held various marketing roles of increasing responsibility at Smith & Nephew and Stryker.
Before his medical device career, Chris was a field artillery captain in the United States Army for five years. Chris holds a Bachelor of Science degree in Mathematical Sciences from the United States Military Academy at West Point.